Pangea Bio
$2.9M
Funding date
Valuation / Funding
No funding history available
Funding data has not been imported for this company yet
Current Valuation Metrics
Pangea Bio is currently valued at $78.7M as of October 28, 2024. The company has raised a total of $20.5M in funding.
Capital Efficiency
With a capital efficiency ratio of 3.83x, Pangea Bio has achieved a valuation that is 3.83 times the total capital raised. This metric indicates strong capital efficiency and effective deployment of investor funds.
Investment Perspective
Pangea Bio's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.
What is Pangea Bio Worth in 2025?
As of 2025, Pangea Bio is valued at $78.7M, based on the company's Early Stage VC funding round in October 28, 2024. This valuation positions Pangea Bio as one of the leading private companies in the sector.
Pangea Bio Valuation History
Pangea Bio's funding history demonstrates steady growth and investor confidence.
How Pangea Bio Valuation is Determined
Private company valuations like Pangea Bio's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:
- Revenue growth and financial performance
- Market opportunity and total addressable market (TAM)
- Competitive positioning and market share
- Management team strength and execution capability
- Technology and intellectual property
- Industry trends and investor sentiment
Pangea Bio Valuation FAQs
Is Pangea Bio profitable?
Pangea Bio has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.
How does Pangea Bio's valuation compare to competitors?
Pangea Bio is valued at $78.7M, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.
When will Pangea Bio IPO?
Pangea Bio has not announced plans for an initial public offering. Until an IPO, investors can access Pangea Bio shares through secondary market platforms.